Callan Family Office’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$7.44M	Buy	16,715 +11,198	+203%	+$4.99M	0.23%	95
2025 Q1	$2.67M	Buy	5,517 +3,067	+125%	+$1.49M	0.2%	109
2024 Q4	$987K	Buy	+2,450	New	+$987K	0.06%	257